IRIS
ARMENI, PATRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.578
NA - Nord America 6.188
AS - Asia 3.237
SA - Sud America 350
AF - Africa 96
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 19.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.904
IT - Italia 3.383
RU - Federazione Russa 1.914
FI - Finlandia 1.023
CN - Cina 1.008
GB - Regno Unito 854
SG - Singapore 828
IE - Irlanda 719
UA - Ucraina 349
DE - Germania 345
VN - Vietnam 341
FR - Francia 289
BR - Brasile 284
HK - Hong Kong 223
CA - Canada 215
SE - Svezia 173
TR - Turchia 161
NL - Olanda 143
IN - India 139
KR - Corea 126
BD - Bangladesh 86
CZ - Repubblica Ceca 61
PL - Polonia 56
BG - Bulgaria 50
ZA - Sudafrica 50
ID - Indonesia 49
ES - Italia 48
IL - Israele 45
BE - Belgio 43
MX - Messico 43
IQ - Iraq 32
JP - Giappone 31
AT - Austria 28
AR - Argentina 26
CH - Svizzera 22
PK - Pakistan 22
AE - Emirati Arabi Uniti 16
IR - Iran 16
RO - Romania 14
AU - Australia 13
DK - Danimarca 12
MA - Marocco 11
PH - Filippine 11
UZ - Uzbekistan 11
CL - Cile 10
CO - Colombia 10
MY - Malesia 10
TH - Thailandia 10
EC - Ecuador 9
PT - Portogallo 9
TW - Taiwan 9
EU - Europa 8
GR - Grecia 8
JO - Giordania 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
GE - Georgia 6
KE - Kenya 6
LT - Lituania 6
LV - Lettonia 6
PA - Panama 6
AM - Armenia 5
EG - Egitto 5
HN - Honduras 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
CR - Costa Rica 4
KG - Kirghizistan 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
SI - Slovenia 4
DZ - Algeria 3
HU - Ungheria 3
NO - Norvegia 3
PE - Perù 3
PS - Palestinian Territory 3
SN - Senegal 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
GT - Guatemala 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
OM - Oman 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
UG - Uganda 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 19.455
Salva come PNG Salva come JPEG
Città #
Helsinki 957
San Jose 838
Ashburn 795
Milan 721
Dublin 717
Southend 532
Chandler 484
Singapore 433
Dallas 370
Moscow 356
Hefei 353
Rome 290
Jacksonville 276
Ann Arbor 234
Beijing 225
Hong Kong 218
New York 177
The Dalles 156
Toronto 153
Los Angeles 141
Dearborn 128
Seoul 125
Houston 107
Dong Ket 104
Edison 93
Ho Chi Minh City 88
Wilmington 80
Boston 77
Lauterbourg 75
Council Bluffs 72
Modena 70
Naples 67
Boardman 64
Lawrence 64
Bologna 59
Munich 58
Izmir 56
Bari 50
Hanoi 47
Johannesburg 46
Buffalo 45
Frankfurt am Main 43
Jakarta 41
Redwood City 41
São Paulo 41
Turin 41
Warsaw 41
Tel Aviv 40
Brussels 39
Florence 39
Redmond 39
Seattle 36
Catania 35
Orem 35
Mountain View 34
Woodbridge 33
Assago 32
Chennai 32
Genoa 32
Amsterdam 30
Casorate Primo 30
London 30
Montreal 30
Brooklyn 27
Tokyo 27
Santa Clara 26
Falkenstein 23
Chicago 20
Cagliari 19
Lappeenranta 19
Brno 18
Duncan 18
Kunming 18
Mexico City 18
Nanjing 18
Palermo 18
Denver 17
Atlanta 16
Brescia 16
Poplar 16
Busto Arsizio 15
Paris 15
Pescara 15
Pisa 15
Stockholm 15
Washington 15
Parma 14
Phoenix 14
Baghdad 13
Palombara Sabina 13
Torino 13
Verona 13
Bonndorf 12
Kocaeli 12
Monza 12
Vienna 12
Ankara 11
Berlin 11
Boydton 11
Rio de Janeiro 11
Totale 11.391
Salva come PNG Salva come JPEG
Nome #
Digitalizzazione nelle tecnologie per la salute: impatto sui livelli di governo del SSN 708
The cost of patients with chronic kidney failure before dialysis: results from the IRIDE observational study 449
Prezzi di riferimento per dispositivi medici: criticità, vantaggi e approcci 436
Politiche del farmaco ed impatto sulla spesa: gli effetti di quindici anni di decentramento nel SSN, con un focus sull’adozione di forme alternative di distribuzione dei farmaci 421
Dinamiche economiche e performance del settore dei dispositivi medici in Italia 390
La copertura vaccinale nelle regioni italiane. Un’analisi dell’eterogeneità 368
La spesa sanitaria: composizione ed evoluzione 365
Report n. 42 OSFAR (Osservatorio Farmaci) 356
I dispositivi medici in Italia: un settore, tanti mercati 340
PDTA per la chirurgia bariatrica: l'esperienza di 6 centri italiani 324
De innovatione: the concept of innovation for medical technologies and its implications for healthcare policy-making 315
Cost-effectiveness and net monetary benefit of durvalumab consolidation therapy versus no consolidation therapy after chemoradiotherapy in stage III non–small cell lung cancer in the Italian National Health Service 309
La rendicontazione e la remunerazione dei farmaci. Finalità, struttura e gestione del File F in nove Regioni italiane 302
Il governo dell'assistenza farmaceutica in Italia: possibili traiettorie di cambiamento 299
L'acquisto di farmaci in Italia: l'effetto di approcci selettivi 289
Cost-minimization analysis to support the HTA of Radiofrequency Echographic Multi Spectrometry (REMS) in the diagnosis of osteoporosis 284
Il confronto dei sistemi sanitari in una prospettiva internazionale 282
Market access management by pharmaceutical companies in a complex environment: the Italian case study 281
Establishing a national HTA program for medical devices in Italy: overhauling a fragmented system to ensure value and equal access to new medical technologies 274
The future of Funds for Innovative Medicines: results from a Delphi Study 270
Cost-utility analysis of esketamine for patients with treatment resistant depression in Italy 268
Diffusion without evidence: a study on high-risk medical devices 263
A value-based revolution in health care: perspectives, challenges, and emerging approaches to defining and measuring the value of health care technologies 260
Real-world cost effectiveness of MitraClip combined with medical therapy versus medical therapy alone in patients with moderate or severe mitral regurgitation 256
Il governo regionale dell'assistenza farmaceutica e il suo impatto sulla spesa 255
Comparative effectiveness of Mitraclip plus medical therapy versus medical therapy alone in high-risk surgical patients: a comprehensive review 252
La spesa sanitaria: composizione ed evoluzione 249
PHP3 the simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 245
Programma Nazionale di HTA per dispositivi medici: prove tecniche di implementazione 243
Collecting physicians' preferences on medical devices: are we doing it right? Evidence from Italian orthopedists using 2 different stated preference methods 239
Digital Twins in healthcare: is it the beginning of a new era of evidence-based medicine? A critical review 237
L'adozione dell'innovazione tecnologica da parte degli ospedali italiani: un'analisi dei fattori endogeni 236
Programmi di early access dei farmaci e managed entry agreement in Italia: i risultati di un Focus Group (programmi di early access e managed entry agreement) 236
Il confronto dei sistemi sanitari in una prospettiva internazionale 235
La spesa sanitaria: composizione ed evoluzione 233
Cost-benefit analysis in health care: the case of bariatric surgery compared with diet 232
Il confronto dei sistemi sanitari in una prospettiva internazionale 231
I settori contigui alla sanità: struttura e performance delle imprese farmaceutiche, di dispositivi medici e delle farmacie in Italia 225
La spesa sanitaria: composizione ed evoluzione 222
The impact of HTA and procurement practices on the selection and prices of medical devices 222
Cost-effectiveness and net monetary benefit of Olaparib maintenance therapy versus no maintenance therapy after first-line platinum-based chemotherapy in newly diagnosed advanced BRCA1/2-mutated ovarian cancer in the Italian National Health Service 220
A meta-analysis of MitraClip combined with medical therapy versus medical therapy alone for treatment of mitral regurgitation in heart failure patients 215
Implementation of value-based pricing for medicines 212
The invisible costs of obstructive sleep apnea (OSA): systematic review and cost-of-illness analysis 206
Politiche del farmaco: approfondimento sul Value Framework per i farmaci 203
L'attività sperimentale sui dispositivi medici 199
Il confronto dei sistemi sanitari in una prospettiva internazionale 199
The impact of generic reference pricing in Italy, a decade on 197
Il confronto dei sistemi sanitari in una prospettiva internazionale 196
Cost-effectiveness analysis of HRD testing for previously treated patients with advanced ovarian cancer in Italy 194
The impact of generic reference pricing in Italy, a decade on 188
When peers count: the effects on integrated type II diabetes care of communication within general practitioner-only subgroups in interprofessional primary care teams 188
La spesa sanitaria: composizione ed evoluzione 188
Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients 183
Mobile health divide between clinicians and patients in cancer care: results from a cross-sectional international survey 181
Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case 180
Economic impact of a more extensive use of FENO testing on the Italian population with asthma 176
Cost-effectiveness analysis of pressure-controlled intermittent coronary sinus occlusion in elective percutaneous coronary intervention 175
The social burden and quality of life of patients with haemophilia in Italy 172
The value of hearing aids for the Italian NHS: a cost-utility analysis 167
La spesa sanitaria: composizione ed evoluzione 165
Cost per responder of Adalimumab biosimilars MSB11022 and ABP 501 versus the originator and methotrexate in chronic plaque psoriasis 164
Multi-professional primary care units: what affects the clinical performance of Italian general practitioners? 162
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 162
Social/economic costs and quality of life in patients with haemophilia in Europe 161
What type of clinical evidence is needed to assess medical devices? 161
La spesa sanitaria: composizione ed evoluzione 161
Il settore dei dispositivi medici in Italia. L’impatto delle politiche pubbliche sulle performance delle imprese 158
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case study 156
L’evoluzione del finanziamento dei farmaci in Italia 153
The simultaneous effects of pharmaceutical policies from payers’ and patients’ perspectives: Italy as a case study 150
Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe 143
Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy 138
Elicitation of societal preferences for chronic lymphocytic leukemia’s treatments: a discrete choice experiment 137
Pharmaceutical pricing and managed entry agreements: An exploratory study on future perspectives in Europe 137
Social economic costs, health-related quality of life and disability in patients with Cri Du Chat syndrome 136
Exploring the potential of digital therapeutics: an assessment of progress and promise 126
Variations in non-prescription drug consumption and expenditure: determinants and policy implications 125
La spesa sanitaria: composizione ed evoluzione 121
La spesa sanitaria: composizione ed evoluzione 119
La spesa sanitaria: composizione ed evoluzione 116
Use of resource modeling to quantify the organizational impact of subcutaneous formulations for the treatment of oncologic patients: the case of daratumumab in multiple myeloma 108
La spesa sanitaria: composizione ed evoluzione 106
Percutaneous mitral valve repair vs. stand-alone medical therapy in patients with functional mitral regurgitation and heart failure 106
Health system quality and COVID-19 vaccination: a cross-sectional analysis in 14 countries 102
Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes 95
Reflections on the importance of cost of illness analysis in rare diseases: a proposal 92
The role of health systems in shaping vaccine decisions: Insights from Italy, Mexico, the United Kingdom, and the United States 85
The economic burden of anesthetic-related adverse events: a systematic review and empirical analysis 78
Individual and team performanc: issues around the role of attributes and relationships among peers 73
The relationship between trust and compliance in the Italian NHS: Results of the People's Voice Survey 58
Promoting healthy aging in a digital world: leveraging technology for enhanced elderly care and wellbeing 27
Implementing the EU HTA regulation and joint clinical assessment: a multi-stakeholder perspective from Italy 16
Organizational impacts of fixed-duration therapies for the management of patients with chronic lymphocytic leukemia in Italy 3
Totale 19.740
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.099
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.099
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 0 0 188
2021/2022935 68 180 36 41 66 12 31 174 41 47 105 134
2022/20232.347 119 127 58 176 153 189 63 101 977 94 165 125
2023/20241.807 104 97 123 89 167 177 105 279 99 136 211 220
2024/20252.490 138 36 170 123 209 157 162 165 571 286 303 170
2025/20268.447 559 647 292 573 605 336 906 837 2.269 896 498 29
Totale 19.740